Contrast-enhanced MRI for quantification of myocardial viability

Journal of Magnetic Resonance Imaging

Volumn 10, Issue 5, 1999, Pages 694-702

  Wendland, Michael F ^a,b   Saeed, Maythem ^a   Lund, Gunnar ^a   Higgins, Charles B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

MRI contrast agents; Myocardial infarction; Myocardial viability

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE DERIVATIVE;

ARTICLE; CONTRAST ENHANCEMENT; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HUMAN; ION TRANSPORT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTITION COEFFICIENT; PRIORITY JOURNAL;

ANIMALS; CONTRAST MEDIA; DYSPROSIUM; EDETIC ACID; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MANGANESE; MYOCARDIAL ISCHEMIA; MYOCARDIAL STUNNING; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; PYRIDOXAL PHOSPHATE;

EID: 0032726702     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199911)10:5<694::AID-JMRI12>3.0.CO;2-J     Document Type: Article

References (55)

1. Bonow RO. Myocardial viability. Curr Prob Cardiol 1996;150-221.
2. Birnbaum Y, Kloner RA. Myocardial viability. West J Med 1996;165: 364-371.
3. Bax JJ, van Eck-Smit BLF, van der Wall EE. Assessment of tissue viability: clinical demand and problems. Eur Heart J 1998;19:847-858.
4. 18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 1995;91:1006-1015.
5. Dendale PA, Franken PR, Waldman GJ, et al. Low-dosage dobutamine magnetic resonance imaging as an alternative to echocardiography in the detection of viable myocardium after acute infarction. Am Heart J 1995;130:134-140.
6. Baer FM, Voth E, LaRosee K, et al. Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. Am J Cardiol 1996;78:415-419.
7. Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998;31:1040-1048.
8. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999;99:763-770.
9. 23Na magnetic resonance imaging of acute reperfused myocardial infarction. Potential to assess myocardial viability. Circulation 1997;95:1877-1885.
10. Diesbourg LD, Prato FS, Wisenberg G, et al. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn Reson Med 1992;23:239-253.
11. Wedeking P, Sotak CH, Telser J, et al. Quantitative dependence of MR signal intensity on tissue concentration of Gd(HP-DO3A) in the nephrectomized rat. Magn Reson Imaging 1992;10:97-108.
12. Donahue KM, Burstein D, Manning WJ, Gray ML. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn Reson Med 1994;32:66-75.
13. Donahue KM, Weisskoff RM, Burstein D. Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging 1997;7:102-110.
14. Tong CY, Prato FS, Wisenberg G, et al. Techniques for the measurement of the local myocardial extraction efficiency for inert diffusible contrast agents such as gadopentate dimeglumine. Magn Reson Med 1993;30:332-336.
15. Tong CY, Prato FS, Wisenberg G, et al. Measurement of the extraction efficiency and distribution volume for Gd-DTPA in normal and diseased canine myocardium. Magn Reson Med 1993;30: 337-346.
16. Pereira RS, Prato FS, Wisenberg G, Sykes J. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med 1996;36: 684-693.
17. Pereira RS, Prato FS, Sykes J, Wisenbery G. Assessment of myocardial viability using MRI during a constant infusion of Gd-DTPA: further studies at early and late periods of reperfusion. Magn Reson Med 1999;42:60-68.
18. Lassen NA, Perl W. Tracer kinetic methods in medical physiology. New York: Raven Press, 1979.
19. Eichstaedt H, Felix R, Dougherty F, et al. Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium-DTPA. Clin Cardiol 1986;9:527-535.
20. Nishimura T, Kobayashi H, Ohara Y, et al. Serial assessment of myocardial infarction by using gated MR imaging and Gd-DTPA. AJR 1989;153:715-720.
21. van Dijkman PR, van der Wall EE, de Roos A, et al. Acute, subacute, and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images. Radiology 1991;180:147-151.
22. Donahue KM, Weisskoff RM, Parmlee DJ, et al. Dynamic GdDTPA enhanced MRI measurement of tissue cell volume fraction. Magn Reson Med 1995;34:423-432.
23. Saeed M, Wendland MF, Masui T, Higgins CB. Reperfused myocardial infarctions on T1-and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media. Magn Reson Med 1994;31:31-39.
24. Geschwind JF, Wendland MF, Saeed M, et al. Identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging. Acad Radiol 1994;1:319-325.
25. Wendland MF, Saeed M, Geschwind JF, et al. Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus GD-DTPA on inversion recovery EPI. Magn Reson Med 1997;37:448-456.
26. 99mTc-DTPA autoradiography in rats. Radiology 1999;211:698-708.
27. Arheden H, Saeed M, Higgins CB, et al. Non-invasive estimation of non-viable cell fraction in acute myocardial injury using echoplanar magnetic resonance imaging. Radiology (submitted).
28. Kety SS. The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 1951;3:1-41.
29. Harris PA, Lorenz CH, Holburn GE, Overholser KA. Regional measurement of the Gd-DTPA tissue partition coefficient in canine myocardium. Magn Reson Med 1997;38:541-545.
30. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-508.
31. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 1989;80:1846-1861.
32. Saeed M, Wendland MF, Yu KK, et al. Identification of myocardial reperfusion with echo planar magnetic resonance imaging. Discrimination between occlusive and reperfused infarctions. Circulation 1994;90:1492-1501.
33. Lima JA, Judd RM, Bazille A, et al. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 1995;92:1117-1125.
34. Judd KM, Reeder SB, Atalar E, McVeigh ER, Zerhouni EA. A magnetization-driven gradient echo pulse sequence for the study of myocardial perfusion. Magn Reson Med 1995;34:276-282.
35. Judd RM, Lugo-Olivieri CH, Aral M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995;92: 1902-1910.
36. Rochitte CE, Lima JA, Bluemke DA, et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998;98:1006-1014.
37. Wu KC, Kim RJ, Bluemke DA, et al. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol 1998;32:1756-1764.
38. 1 contrast enhanced MR imaging in reperfused myocardial infarction: a histopathologic correlation. In: Proceedings of the ISMRM Annual Meeting, 1999. p 212.
39. Dendale P, Franken PR, Block P, Pratikakis Y, de Roos A. Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction. Am Heart J 1998; 135:875-880.
40. Rogers WJ Jr, Kramer CM, Geskin G, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction [see comments]. Circulation 1999;99:744-750.
41. Kramer CM, Rogers WJ, Mankad S, et al. Complementary utility of dobutamine tagged and contrast enhanced MRI for assessment of viability after myocardial infarction. In: Proceedings of the ISMRM Annual Meeting, 1999. p 218.
42. Ni Y, Marchal G, Yu J, et al. Localization of metalloporphyrin-induced "specific" enhancement in experimental liver tumors: comparison of magnetic resonance imaging, microangiographic, and histologic findings. Acad Radiol 1995;2:687-699.
43. Ni Y, Petre C, Miao Y, et al. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis. Invest Radiol 1997;32:770-779.
44. Ni Y, Marchal G, Herijgers P, et al. Paramagnetic metalloporphyrins: from enhancers of malignant tumors to markers of myocardial infarcts. Acad Radiol 1996;3(suppl 2):S395-397.
45. Marchal G, Ni Y, Herijgers P, et al. Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI. Eur Radiol 1996;6:2-8.
46. Pislaru SV, Ni Y, Pislaru C, et al. Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent. Circulation 1999;99:690-696.
47. Saeed M, Bremerich J, Wendland MF, et al. Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. Radiology 1999;213:247-257.
48. Pomeroy OH, Wendland M, Wagner S, et al. Magnetic resonance imaging of acute myocardial ischemia using a manganese chelate. Mn-DPDP. Invest Radiol 1989;24:531-536.
49. Saeed M, Wagner S, Wendland MF, et al. Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP-enhanced MR imaging. Radiology 1989;172:59-64.
50. Gallez B, Bacic G, Swartz H. Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP. Magn Reson Med 1996;35:14-19.
51. 2 on cardiac energy metabolism and manganese accumulation. An experimental study in the isolated perfused rat heart. Invest Radiol 1997;32:205-211.
52. 2 and MnDPDP on the isolated and perfused rat heart. Invest Radiol 1997;32:581-588.
53. Saeed M, Higgins CB, Geschwind JF, Wendland MF. T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echoplanar MI imaging. Eur Radiol (in press).
54. Bremerich J, Saeed M, Arheden H, Higgins CB, Wendland MF. Differentiation between normal and infarcted myocardium by myocardial cellular uptake of manganese. Radiology (in press).
55. Brurok H, Ardenkjaer-Larsen JH, Hansson G, et al. Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties? Biochem Biophys Res Commun 1999; 254:768-772.